Parexel is one of the world's largest clinical research organizations (CROs), providing insights-driven clinical and consulting solutions to the global life sciences industry. Founded in 1982 in Cambridge, Massachusetts, the company offers the full range of Phase I to IV clinical development services, including clinical trial management, data management, biostatistics, medical writing, pharmacovigilance, and regulatory consulting. Parexel works in partnership with biopharmaceutical leaders and emerging innovators, with more than 24,000 global professionals operating across dozens of countries. It was publicly listed on NASDAQ in 1995 and has been privately held since being acquired by private equity firms in 2017 and again in 2021.
| Import | Export |
|---|---|
|
Trade Records
543
|
Trade Records
55
|
|
Suppliers
-
|
Buyers
-
|
|
Latest Import Date
2026-06
|
Latest Export Date
2026-06
|
According to Topease's global trade data, PAREXEL INTERNATIONAL S A exports products to verified importers across global markets.
Its export activity is associated with HS-code categories such as:
As an importer, PAREXEL INTERNATIONAL S A sources products from verified exporters across multiple regions.
Its import activity spans HS-code categories including:
Explore PAREXEL INTERNATIONAL S A's import activity, including trade volumes, top suppliers, sourcing countries, and key product categories. These insights allow exporters and potential suppliers to understand its global supply chains, track procurement trends, and identify new business opportunities.
Gain insights into PAREXEL INTERNATIONAL S A's export activities, including shipment volumes, key buyers, destination countries, and product categories. Understand global demand patterns, track sales reach, and spot opportunities to connect with potential buyers.
Access PAREXEL INTERNATIONAL S A's key professional contacts for B2B outreach purposes. View verified phone numbers, emails, and LinkedIn profiles to facilitate efficient business communication.
Disclaimer: Data is compiled from public and third-party sources and may not be complete or fully accurate. This information is provided for business intelligence purposes only and should not be used for legal, financial, or compliance decisions.